DownloadHi-Res Photo

Henry S. Park, MD, MPH

Associate Professor of Therapeutic Radiology; Vice Chair for Clinical Research, Therapeutic Radiology; Chief, Thoracic Radiotherapy Program, Therapeutic Radiology

Research & Publications
Biography
News
Locations

Research Summary

As a radiation oncologist and epidemiologist, my research focuses on evaluating determinants of population-based outcomes, health services utilization, and medical decision-making for patients with cancer. I have used national and institutional observational databases as well as systematic reviews and meta-analyses to gain insight into how clinical, demographic, and health system factors affect quality of care and outcomes. I also highly prioritize the use of innovative statistical methods to minimize the inherent biases of retrospective analysis, having led the development of a tool known as sequential landmark analysis to control for immortal time bias when interpreting observational analyses studying the survival impact of adjuvant radiation therapy. Furthermore, I am interested in pragmatic clinical trial design and reducing barriers to trial accrual among disadvantaged populations through community-based participatory research.

I have co-authored over 120 peer-reviewed original research articles and 40 reviews, book chapters, and invited editorials. I also direct the Yale Radiation Oncology Consortium (YROC), lead the Therapeutic Radiology disease-aligned research team (DART) for clinical trials, and collaborate closely with the Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center (COPPER). I am also interested in mentoring medical students, residents, and junior faculty in clinical trials, comparative effectiveness research, and health services research, especially in projects relating to lung cancer and head and neck cancer.

Extensive Research Description

Population-based Outcomes; Health Services Utilization; Health Disparities; Clinical Trials

Coauthors

Research Interests

Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Lung Neoplasms; Radiation; Small Cell Lung Carcinoma; Mentoring

Selected Publications

Outcomes stratification of head and neck cancer using pre- and post-treatment DNA methylation from peripheral bloodQian D, Ulrich B, Peng G, Zhao H, Conneely K, Miller A, Bruner D, Eldridge R, Wommack E, Higgins K, Shin D, Saba N, Smith A, Burtness B, Park H, Stokes W, Beitler J, Xiao C. Outcomes stratification of head and neck cancer using pre- and post-treatment DNA methylation from peripheral blood International Journal Of Radiation Oncology • Biology • Physics 2022 PMID: 36410685, DOI: 10.1016/j.ijrobp.2022.11.009.
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung TumorsWallington D, Verma N, Laird J, Aneja S, Park H, Yang D. Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e407-e408. DOI: 10.1016/j.ijrobp.2022.07.1584.
Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable AnalysisKing ALO, Lee V, Mirza FN, Jairam V, Yang DX, Yu JB, Park HS, Girardi M, Wilson LD, An Y. Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable Analysis Cureus 2022, 14: e28043. PMID: 36120198, PMCID: PMC9474264, DOI: 10.7759/cureus.28043.
Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung CancerPichert MD, Canavan ME, Maduka RC, Li AX, Ermer T, Zhan PL, Kaminski M, Udelsman BV, Blasberg JD, Park HS, Goldberg SB, Boffa DJ. Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer JAMA Network Open 2022, 5: e2224478. PMID: 35925606, PMCID: PMC9353596, DOI: 10.1001/jamanetworkopen.2022.24478.
Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.Gao S, Jin L, Moliterno J, Corbin ZA, Bindra RS, Contessa JN, Yu JB, Park HS. Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma. Journal Of Neurosurgery 2022, 1-11. PMID: 35907197, DOI: 10.3171/2022.5.jns212761.
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-makingDetterbeck FC, Blasberg JD, Woodard GA, Decker RH, Kumbasar U, Park HS, Mase VJ, Bade BC, Li AX, Brandt WS, Madoff DC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-making Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813719, PMCID: PMC9264102, DOI: 10.21037/jtd-21-1823.
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patientsDetterbeck FC, Mase VJ, Li AX, Kumbasar U, Bade BC, Park HS, Decker RH, Madoff DC, Woodard GA, Brandt WS, Blasberg JD. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813747, PMCID: PMC9264068, DOI: 10.21037/jtd-21-1824.
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumorsBade BC, Blasberg JD, Mase VJ, Kumbasar U, Li AX, Park HS, Decker RH, Madoff DC, Brandt WS, Woodard GA, Detterbeck FC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813753, PMCID: PMC9264070, DOI: 10.21037/jtd-21-1825.
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablationPark HS, Detterbeck FC, Madoff DC, Bade BC, Kumbasar U, Mase VJ, Li AX, Blasberg JD, Woodard GA, Brandt WS, Decker RH. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813762, PMCID: PMC9264060, DOI: 10.21037/jtd-21-1826.
Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.Haque W, Singh A, Park HS, Teh BS, Butler EB, Zeng M, Lin SH, Welsh JW, Chang JY, Verma V. Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer. Acta Oncologica (Stockholm, Sweden) 2022, 61: 403-408. PMID: 34913815, DOI: 10.1080/0284186X.2021.2012253.
Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole-Brain Radiation TherapyJairam V, Park HS, Yu JB, Bindra RS, Contessa JN, Jethwa KR. Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole-Brain Radiation Therapy Advances In Radiation Oncology 2022, 7: 100949. PMID: 35521071, PMCID: PMC9065721, DOI: 10.1016/j.adro.2022.100949.
Nonadherence to Multimodality Cancer Treatment Guidelines in the United StatesTchelebi LT, Shen B, Wang M, Potters L, Herman J, Boffa D, Segel JE, Park HS, Zaorsky NG. Nonadherence to Multimodality Cancer Treatment Guidelines in the United States Advances In Radiation Oncology 2022, 7: 100938. PMID: 35469182, PMCID: PMC9034283, DOI: 10.1016/j.adro.2022.100938.
Less Is More: Lower Doses for Intermediate-Term Oropharyngeal ControlJohung KL, Park HS. Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control International Journal Of Radiation Oncology • Biology • Physics 2022, 112: 585. PMID: 35101192, DOI: 10.1016/j.ijrobp.2021.07.1707.
Consolidative Thoracic Radiation Therapy After First-Line Chemotherapy and Immunotherapy in Extensive-Stage Small Cell Lung Cancer: A Multi-Institutional Case Series.Diamond BH, Verma N, Shukla UC, Park HS, Koffer PP. Consolidative Thoracic Radiation Therapy After First-Line Chemotherapy and Immunotherapy in Extensive-Stage Small Cell Lung Cancer: A Multi-Institutional Case Series. Advances In Radiation Oncology 2022, 7: 100883. PMID: 35387416, PMCID: PMC8977911, DOI: 10.1016/j.adro.2021.100883.
Hypofractionated vs . standard radiotherapy for locally advanced limited-stage small cell lung cancerSaeed NA, Jin L, Sasse AW, Amini A, Verma V, Lester-Coll NH, Chen PH, Decker RH, Park HS. Hypofractionated vs . standard radiotherapy for locally advanced limited-stage small cell lung cancer Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35280466, PMCID: PMC8902118, DOI: 10.21037/jtd-21-1566.
Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer ScreeningLeapman MS, Wang R, Park H, Yu JB, Sprenkle PC, Cooperberg MR, Gross CP, Ma X. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening JAMA Oncology 2022, 8: 41-47. PMID: 34762100, PMCID: PMC8587214, DOI: 10.1001/jamaoncol.2021.5143.
Facility-Level Variation in Use of Locoregional Therapy for Metastatic Prostate CancerBuck M, Ghiraldi E, Demkowicz P, Park H, An Y, Kann B, Yu J, Sprenkle P, Kim I, Leapman M. Facility-Level Variation in Use of Locoregional Therapy for Metastatic Prostate Cancer Urology Practice 2021, 9: 141-149. DOI: 10.1097/upj.0000000000000290.
A reply to “Randomized controlled clinical trial is needed for toxicity of IMRT VS 3D-CRT in PORT for LA-NSCLC”Jairam V, Soulos PR, Gross CP, Yu JB, Park HS, Decker RH. A reply to “Randomized controlled clinical trial is needed for toxicity of IMRT VS 3D-CRT in PORT for LA-NSCLC” Lung Cancer 2021, 168: 84-85. PMID: 34933760, DOI: 10.1016/j.lungcan.2021.12.003.
Emergency department visits for radiation cystitis among patients with a prostate cancer historyLee V, An Y, Park HS, Yu JB, Kim SP, Jairam V. Emergency department visits for radiation cystitis among patients with a prostate cancer history BJU International 2021, 130: 208-216. PMID: 34806813, DOI: 10.1111/bju.15650.
Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation TherapyRaju SC, Peters GW, Decker RH, Park HS. Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy Practical Radiation Oncology 2021, 12: e110-e116. PMID: 34861443, DOI: 10.1016/j.prro.2021.11.006.
Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal CancerPeters G, Wang S, Peters N, Dhanasopan A, Lacy J, Cecchini M, Kortmansky J, Stein S, Kunz P, Lattanzi S, Park H, Boffa D, Johung K, Jethwa K. Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e68. DOI: 10.1016/j.ijrobp.2021.07.422.
Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole-Brain Radiation TherapyJairam V, Park H, Yu J, Bindra R, Contessa J, Jethwa K. Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole-Brain Radiation Therapy International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e569. DOI: 10.1016/j.ijrobp.2021.07.1536.
Comparison of Machine Learning Approaches for Missing Data Imputation Among Non-Small Cell Lung Cancer PatientsYang D, Khera R, Chang E, Joel M, Janda G, Park H, Aneja S. Comparison of Machine Learning Approaches for Missing Data Imputation Among Non-Small Cell Lung Cancer Patients International Journal Of Radiation Oncology • Biology • Physics 2021, 111: s115. DOI: 10.1016/j.ijrobp.2021.07.264.
Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal BrachytherapyLi J, Park H, Huang G, Young M, Ratner E, Santin A, Damast S. Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal Brachytherapy International Journal Of Radiation Oncology • Biology • Physics 2021, 111: s138. DOI: 10.1016/j.ijrobp.2021.07.311.
Multi-Institutional Outcomes and Perspectives From Medical Students After Virtual Radiation Oncology ElectivesWairiri L, Fields E, Kumar K, Rosenberg S, Park H, Frakes J, Beriwal S, Parekh A, Stadtlander W, Thomas C, Kahn J. Multi-Institutional Outcomes and Perspectives From Medical Students After Virtual Radiation Oncology Electives International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e193-e194. DOI: 10.1016/j.ijrobp.2021.07.702.
Multi-Institutional Virtual Medical Student Clerkship in Radiation OncologyWairiri L, Fields E, Kumar K, Rosenberg S, Park H, Frakes J, Beriwal S, Parekh A, Stadtlander W, Thomas C, Kahn J. Multi-Institutional Virtual Medical Student Clerkship in Radiation Oncology International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e194. DOI: 10.1016/j.ijrobp.2021.07.703.
Association of Heart and Lung Radiation Dose With COVID-Related MortalityTalcott W, Peters G, Yu J, Park H. Association of Heart and Lung Radiation Dose With COVID-Related Mortality International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e424-e425. PMCID: PMC8536215, DOI: 10.1016/j.ijrobp.2021.07.1212.
Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapyLi JY, Park HS, Huang GS, Young MR, Ratner E, Santin A, Damast S. Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy Gynecologic Oncology 2021, 163: 557-562. PMID: 34602287, DOI: 10.1016/j.ygyno.2021.09.018.
Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer ManagementLeapman MS, Wang R, Park HS, Yu JB, Sprenkle PC, Dinan MA, Ma X, Gross CP. Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management JAMA Network Open 2021, 4: e2128646. PMID: 34623406, PMCID: PMC8501394, DOI: 10.1001/jamanetworkopen.2021.28646.
Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniquesJairam V, Pasha S, Soulos PR, Gross CP, Yu JB, Park HS, Decker RH. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques Lung Cancer 2021, 161: 171-179. PMID: 34607209, DOI: 10.1016/j.lungcan.2021.09.010.
Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United StatesMattes MD, Suneja G, Haffty BG, Takita C, Katz MS, Ohri N, Deville C, Siker ML, Park HS. Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States Advances In Radiation Oncology 2021, 6: 100802. PMID: 34693080, PMCID: PMC8515237, DOI: 10.1016/j.adro.2021.100802.
Social Connectedness Among Medicare Beneficiaries Following the Onset of the COVID-19 PandemicTalcott WJ, Yu JB, Gross CP, Park HS. Social Connectedness Among Medicare Beneficiaries Following the Onset of the COVID-19 Pandemic JAMA Internal Medicine 2021, 181: 1245-1248. PMID: 34047760, PMCID: PMC8424484, DOI: 10.1001/jamainternmed.2021.2348.
Effect of prior thoracic radiotherapy on prognosis in relapsed small cell lung cancer patients treated with anlotinib: a subgroup analysis of the ALTER 1202 trial.Liu Y, Cheng Y, Li K, Shi J, Liu Y, Wu L, Han B, Chen G, He J, Wang J, Qin H, Li X, Hamaji M, Park HS. Effect of prior thoracic radiotherapy on prognosis in relapsed small cell lung cancer patients treated with anlotinib: a subgroup analysis of the ALTER 1202 trial. Translational Lung Cancer Research 2021, 10: 3793-3806. PMID: 34733629, PMCID: PMC8512470, DOI: 10.21037/tlcr-21-632.
Implementation of a Multi-Institutional Virtual Radiation Oncology ClerkshipWairiri L, Fields E, Kumar K, Rosenberg S, Park H, Frakes J, Beriwal S, Parekh A, Stadtlander W, Thomas C, Kahn J. Implementation of a Multi-Institutional Virtual Radiation Oncology Clerkship International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e8-e9. DOI: 10.1016/j.ijrobp.2021.05.150.
Pan‐cancer analysis of prognostic metastatic phenotypesZaorsky NG, Wang X, Garrett SM, Lehrer EJ, Lin C, DeGraff DJ, Spratt DE, Trifiletti DM, Kishan AU, Showalter TN, Park HS, Yang JT, Chinchilli VM, Wang M. Pan‐cancer analysis of prognostic metastatic phenotypes International Journal Of Cancer 2021, 150: 132-141. PMID: 34287840, PMCID: PMC8595638, DOI: 10.1002/ijc.33744.
Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trialsMetzger AL, Appiah A, Wright CM, Jairam V, Amini A, Park HS, Welsh JW, Thomas CR, Verma V, Ludmir EB. Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trials International Journal Of Cancer 2021, 149: 1683-1690. PMID: 34173669, DOI: 10.1002/ijc.33719.
Rates of Invasive Disease and Outcomes in NSCLC Patients with Biopsy Suggestive of Carcinoma in SituTalcott WJ, Miccio JA, Park HS, White AA, Kozono DE, Singer L, Sands JM, Sholl LM, Detterbeck FC, Mak RH, Decker RH, Kann BH. Rates of Invasive Disease and Outcomes in NSCLC Patients with Biopsy Suggestive of Carcinoma in Situ Lung Cancer 2021, 157: 17-20. PMID: 34052704, DOI: 10.1016/j.lungcan.2021.05.028.
Adoption of consolidative durvalumab among patients with locally advanced non-small cell lung cancer.Jairam V, Pasha S, Pasha S, Soulos P, Soulos P, Goldberg S, Yu J, Yu J, Decker R, Gross C, Park H. Adoption of consolidative durvalumab among patients with locally advanced non-small cell lung cancer. Journal Of Clinical Oncology 2021, 39: e20550-e20550. DOI: 10.1200/jco.2021.39.15_suppl.e20550.
Leveraging Surgical Case Volume in Improving Cancer Care Outcomes: Where Do We Go From Here?Park HS. Leveraging Surgical Case Volume in Improving Cancer Care Outcomes: Where Do We Go From Here? Journal Of The National Comprehensive Cancer Network : JNCCN 2021, 19: 577-579. PMID: 34030129, DOI: 10.6004/jnccn.2021.7045.
Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative reviewHayman TJ, Bhatia AK, Jethwa KR, Young MR, Park HS. Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review Translational Cancer Research 2021, 10: 2571-2585. PMID: 35116571, PMCID: PMC8798834, DOI: 10.21037/tcr-20-2096.
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck CancerXiao C, Miller AH, Peng G, Levine ME, Conneely KN, Zhao H, Eldridge RC, Wommack EC, Jeon S, Higgins KA, Shin DM, Saba NF, Smith AK, Burtness B, Park HS, Irwin ML, Ferrucci LM, Ulrich B, Qian DC, Beitler JJ, Bruner DW. Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer International Journal Of Radiation Oncology • Biology • Physics 2021, 111: 157-167. PMID: 33882281, PMCID: PMC8802868, DOI: 10.1016/j.ijrobp.2021.04.002.
Genomic Characterization of Radiation-Induced Intracranial Undifferentiated Pleomorphic SarcomaHong CS, Partovi E, Clune J, Huttner A, Park HS, Omay SB. Genomic Characterization of Radiation-Induced Intracranial Undifferentiated Pleomorphic Sarcoma Case Reports In Genetics 2021, 2021: 5586072. PMID: 33747576, PMCID: PMC7960067, DOI: 10.1155/2021/5586072.
Prevalence of Missing Data in the National Cancer Database and Association With Overall SurvivalYang DX, Khera R, Miccio JA, Jairam V, Chang E, Yu JB, Park HS, Krumholz HM, Aneja S. Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival JAMA Network Open 2021, 4: e211793. PMID: 33755165, PMCID: PMC7988369, DOI: 10.1001/jamanetworkopen.2021.1793.
Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping systemLee NCJ, Eskander A, Miccio JA, Park HS, Shah C, Rutenberg M, Hosni A, Husain ZA. Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system Oral Oncology 2021, 114: 105137. PMID: 33422859, DOI: 10.1016/j.oraloncology.2020.105137.
Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases up to 3 cm: A multi-institutional retrospective analysis.Diamond BH, Jairam V, Zuberi S, Li JY, Marquis TJ, Rutter CE, Park HS. Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases up to 3 cm: A multi-institutional retrospective analysis. Journal Of Radiosurgery And SBRT 2021, 7: 179-187. PMID: 33898081, PMCID: PMC8055233.
Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung CancerHe Y, Song L, Wang H, Chen P, Liu Y, Sun H, Li X, Dang S, Liu G, Liu X, Chen S, Zhang X, Hofman P, Uchino J, Park HS, Pacheco JM, Tabbò F, Xu M, Dai J, He K, Yang Y, Zhou C, Group W. Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer Advanced Science 2020, 8: 2003263. PMID: 33643802, PMCID: PMC7887584, DOI: 10.1002/advs.202003263.
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysisMiccio JA, Talcott WJ, Patel T, Park HS, Cecchini M, Salem RR, Khan SA, Stein S, Kortmansky JS, Lacy J, Narang A, Herman J, Jabbour SK, Hallemeier CL, Johung K, Jethwa KR. Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis Clinical And Translational Radiation Oncology 2020, 27: 15-23. PMID: 33392398, PMCID: PMC7772693, DOI: 10.1016/j.ctro.2020.12.003.
Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV‐Negative Oropharyngeal CancerJacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV‐Negative Oropharyngeal Cancer Otolaryngology 2020, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.
The Impact of Missing/Incomplete Data in Real-World Data StudiesYang D, Miccio J, Jairam V, Chang E, Yu J, Park H, Aneja S. The Impact of Missing/Incomplete Data in Real-World Data Studies International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e394. DOI: 10.1016/j.ijrobp.2020.07.2432.
Emergency Department Presentations Resulting in Percutaneous Endoscopic Gastrostomy Tube Placement Among Head and Neck Cancer PatientsTalcott W, Blakaj A, Jairam V, Park H. Emergency Department Presentations Resulting in Percutaneous Endoscopic Gastrostomy Tube Placement Among Head and Neck Cancer Patients International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e838-e839. DOI: 10.1016/j.ijrobp.2020.07.378.
Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer: A Comparison of Radiation Therapy TechniquesJairam V, Pasha S, Pasha S, Soulos P, Soulos P, Gross C, Yu J, Yu J, Park H, Decker R. Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer: A Comparison of Radiation Therapy Techniques International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e130. DOI: 10.1016/j.ijrobp.2020.07.1276.
Association of Neoadjuvant Treatment Modality with Negative Margin and Pathologic Downstaging in Patients Undergoing Pancreatic Cancer Resection: A National Cancer Database AnalysisMiccio J, Mokhtech M, Jabbour S, Anker C, Patel T, Park H, Cecchini M, Salem R, Kuntsman J, Stein S, Kortmansky J, Lacy J, Narang A, Herman J, Haddock M, Hallemeier C, Johung K, Jethwa K. Association of Neoadjuvant Treatment Modality with Negative Margin and Pathologic Downstaging in Patients Undergoing Pancreatic Cancer Resection: A National Cancer Database Analysis International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e662. DOI: 10.1016/j.ijrobp.2020.07.1980.
Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non–small cell lung cancer: A network meta‐analysis of randomized trialsPathak R, De Lima Lopes G, Yu H, Aryal MR, Ji W, Frumento KS, Wallis CJD, Klaassen Z, Park HS, Goldberg SB. Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non–small cell lung cancer: A network meta‐analysis of randomized trials Cancer 2020, 127: 709-719. PMID: 33119177, DOI: 10.1002/cncr.33269.
Primary Treatment Selection for Clinically Node‐Negative Merkel Cell Carcinoma of the Head and NeckJacobs D, Olino K, Park HS, Clune J, Cheraghlou S, Girardi M, Burtness B, Kluger H, Judson BL. Primary Treatment Selection for Clinically Node‐Negative Merkel Cell Carcinoma of the Head and Neck Otolaryngology 2020, 164: 1214-1221. PMID: 33079010, DOI: 10.1177/0194599820967001.
Development and Validation of a Deep Learning Algorithm to Predict Radiation Pneumonitis and Esophagitis Following Lung Stereotactic Body Radiation TherapyChang E, Du J, Decker R, Yu J, Park H, Aneja S. Development and Validation of a Deep Learning Algorithm to Predict Radiation Pneumonitis and Esophagitis Following Lung Stereotactic Body Radiation Therapy International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e14. DOI: 10.1016/j.ijrobp.2020.02.496.
Nationwide Patterns of Hemorrhagic Stroke among Patients Hospitalized with Brain Metastases: Influence of Primary Cancer Diagnosis and AnticoagulationPark H, Lee V, Jairam V, Yu J. Nationwide Patterns of Hemorrhagic Stroke among Patients Hospitalized with Brain Metastases: Influence of Primary Cancer Diagnosis and Anticoagulation International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e52-e53. DOI: 10.1016/j.ijrobp.2020.02.593.
The Utility of Neoadjuvant Radiotherapy after Neoadjuvant Multiagent Chemotherapy in Patients with Localized Pancreatic CancerMiccio J, Talcott W, Patel T, Park H, Cecchini M, Salem R, Stein S, Kortmansky J, Lacy J, Johung K, Jethwa K. The Utility of Neoadjuvant Radiotherapy after Neoadjuvant Multiagent Chemotherapy in Patients with Localized Pancreatic Cancer International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e31-e32. DOI: 10.1016/j.ijrobp.2020.02.538.
Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patientsMiccio JA, Talcott WJ, Jairam V, Park HS, Yu JB, Leapman MS, Johnson SB, King MT, Nguyen PL, Kann BH. Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patients Prostate Cancer And Prostatic Diseases 2020, 24: 414-422. PMID: 32989262, DOI: 10.1038/s41391-020-00291-3.
Radiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation TherapyYang DX, Verma V, An Y, Yu JB, Sprenkle PC, Leapman MS, Park HS. Radiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation Therapy Advances In Radiation Oncology 2020, 5: 1225-1231. PMID: 33305083, PMCID: PMC7718530, DOI: 10.1016/j.adro.2020.08.015.
Temporal Trends in Opioid Prescribing Patterns Among Oncologists in the Medicare PopulationJairam V, Yang DX, Pasha S, Soulos PR, Gross CP, Yu JB, Park HS. Temporal Trends in Opioid Prescribing Patterns Among Oncologists in the Medicare Population Journal Of The National Cancer Institute 2020, 113: 274-281. PMID: 32785685, PMCID: PMC7936059, DOI: 10.1093/jnci/djaa110.
National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United StatesJairam V, Yang DX, Verma V, Yu JB, Park HS. National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States JAMA Network Open 2020, 3: e2013605. PMID: 32804217, PMCID: PMC7431994, DOI: 10.1001/jamanetworkopen.2020.13605.
Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone MetastasesJairam V, Lee V, Yu JB, Park HS. Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases American Journal Of Clinical Oncology 2020, 43: 720-726. PMID: 32694296, DOI: 10.1097/coc.0000000000000737.
The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular Cancer.Hsiang W, Han X, Jemal A, Nguyen KA, Shuch B, Park H, Yu JB, Gross CP, Davidoff AJ, Leapman MS. The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular Cancer. Urology Practice 2020, 7: 252-258. PMID: 34017908, PMCID: PMC8130174, DOI: 10.1097/upj.0000000000000109.
Resident attitudes and benefits of mock oral board examinations in radiation oncologyPeters GW, Decker RH, Park HS, Yu JB, Evans SB. Resident attitudes and benefits of mock oral board examinations in radiation oncology BMC Medical Education 2020, 20: 203. PMID: 32586357, PMCID: PMC7318518, DOI: 10.1186/s12909-020-02106-4.
Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulationLee V, Jairam V, Yu JB, Park HS. Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation Scientific Reports 2020, 10: 10084. PMID: 32572113, PMCID: PMC7308286, DOI: 10.1038/s41598-020-67316-8.
National trends in the management of patients with positive surgical margins at radical prostatectomyGhabili K, Park HS, Yu JB, Sprenkle PC, Kim SP, Nguyen KA, Ma X, Gross CP, Leapman MS. National trends in the management of patients with positive surgical margins at radical prostatectomy World Journal Of Urology 2020, 39: 1141-1151. PMID: 32562045, DOI: 10.1007/s00345-020-03298-6.
Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy.Yang D, Jairam V, Park H, Decker R, Chiang A, Gross C, Yu J. Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy. Journal Of Clinical Oncology 2020, 38: e19309-e19309. DOI: 10.1200/jco.2020.38.15_suppl.e19309.
Temporal trends in opioid prescribing patterns among oncologists in the Medicare population.Jairam V, Yang D, Pasha S, Soulos P, Gross C, Yu J, Park H. Temporal trends in opioid prescribing patterns among oncologists in the Medicare population. Journal Of Clinical Oncology 2020, 38: 12022-12022. DOI: 10.1200/jco.2020.38.15_suppl.12022.
Comparative efficacy of chemoimmunotherapy versus immunotherapy alone in the front-line treatment of advanced non-small cell lung cancer: A systematic review and network meta-analysis.Pathak R, Lopes G, Yu H, Ji W, Aryal M, Frumento K, Wallis C, Klaassen Z, Park H, Goldberg S. Comparative efficacy of chemoimmunotherapy versus immunotherapy alone in the front-line treatment of advanced non-small cell lung cancer: A systematic review and network meta-analysis. Journal Of Clinical Oncology 2020, 38: 9552-9552. DOI: 10.1200/jco.2020.38.15_suppl.9552.
Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and NeckJacobs D, Park H, Young M, Olino K, Rahmati R, Mehra S, Burtness B, Judson B. Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and Neck International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1191-1192. DOI: 10.1016/j.ijrobp.2019.11.099.
An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based AnalysisJacobs D, Park H, Young M, Breen C, Rahmati R, Mehra S, Judson B. An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based Analysis International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1145-1146. DOI: 10.1016/j.ijrobp.2019.11.214.
Changing Demographics of Laryngeal Cancer: Are Patients Getting Younger?Jacobs D, Park H, Rahmati R, Mehra S, Judson B. Changing Demographics of Laryngeal Cancer: Are Patients Getting Younger? International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1162-1163. DOI: 10.1016/j.ijrobp.2019.11.186.
Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.Jairam V, Park HS, Decker RH. Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. The Cancer Journal 2020, 26: 129-136. PMID: 32205537, DOI: 10.1097/ppo.0000000000000433.
Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era.Miccio J, Ma S, Oladeru O, Yang D, Peters G, Jethwa K, Park H, Hurwitz M, Leapman M, Sprenkle P, Nguyen P, Yu J, Johung K. Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era. Journal Of Clinical Oncology 2020, 38: 748-748. DOI: 10.1200/jco.2020.38.6_suppl.748.
Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerSaeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer Head & Neck 2020, 42: 1031-1044. PMID: 32011055, DOI: 10.1002/hed.26086.
Proton-Based Chemoradiotherapy—What Level of Evidence Is Necessary to Justify Its Widespread Use?Park HS, Yu JB. Proton-Based Chemoradiotherapy—What Level of Evidence Is Necessary to Justify Its Widespread Use? JAMA Oncology 2020, 6: 246-247. PMID: 31876903, DOI: 10.1001/jamaoncol.2019.4875.
Author Correction: Suicide among cancer patientsZaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM. Author Correction: Suicide among cancer patients Nature Communications 2020, 11: 718. PMID: 32005824, PMCID: PMC6994458, DOI: 10.1038/s41467-020-14506-7.
Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy.Miccio JA, Barsky A, Gao S, Verma V, Noticewala SS, Jairam V, Johnson SB, Yu JB, Hansen JE, Aneja S, An Y, Decker RH, Bulent Omay S, Li J, Kurtz GA, Alonso-Basanta M, Lee JYK, Chiang VL, Park HS. Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy. Journal Of Radiosurgery And SBRT 2020, 7: 19-27. PMID: 32802575, PMCID: PMC7406345.
Emergency Department Visits for Firearm-Related Injuries among Youth in the United States, 2006–2015Lee V, Camp C, Jairam V, Park HS, Yu JB. Emergency Department Visits for Firearm-Related Injuries among Youth in the United States, 2006–2015 The Journal Of Law, Medicine & Ethics 2020, 48: 67-73. PMID: 33404319, DOI: 10.1177/1073110520979403.
Emergency Department Visits for Opioid Overdoses Among Patients With Cancer.Jairam V, Yang DX, Yu JB, Park HS. Emergency Department Visits for Opioid Overdoses Among Patients With Cancer. Journal Of The National Cancer Institute 2019, 112: 938-943. PMID: 31845985, PMCID: PMC7492769, DOI: 10.1093/jnci/djz233.
Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.Kann BH, Hicks DF, Payabvash S, Mahajan A, Du J, Gupta V, Park HS, Yu JB, Yarbrough WG, Burtness BA, Husain ZA, Aneja S. Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma. Journal Of Clinical Oncology 2019, 38: 1304-1311. PMID: 31815574, DOI: 10.1200/jco.19.02031.
Cancer Clinical Trial Enrollment: OK Doc, but What's in It for Me?Park HS. Cancer Clinical Trial Enrollment: OK Doc, but What's in It for Me? Journal Of The National Comprehensive Cancer Network : JNCCN 2019, 17: 1404-1405. PMID: 31693990, DOI: 10.6004/jnccn.2019.7365.
Mentorship in Radiation Oncology: Role of Gender Diversity in Abstract Presenting and Senior Author Dyads on Subsequent High-Impact PublicationsLee A, Albert A, Griffith K, Evans S, Rahimy E, Park HS, Cervino LI, Moran JM, Jagsi R. Mentorship in Radiation Oncology: Role of Gender Diversity in Abstract Presenting and Senior Author Dyads on Subsequent High-Impact Publications Advances In Radiation Oncology 2019, 5: 292-296. PMID: 32280830, PMCID: PMC7136636, DOI: 10.1016/j.adro.2019.10.005.
Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth editionMiccio JA, Verma V, Kelly J, Kann BH, An Y, Park HS, Eskander A, Burtness B, Husain Z. Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition Oral Oncology 2019, 99: 104447. PMID: 31630059, DOI: 10.1016/j.oraloncology.2019.104447.
Outcomes following Lower Extremity Amputation in Patients with Diabetes Mellitus and Peripheral Arterial DiseasePourghaderi P, Yuquimpo KM, Roginski Guetter C, Mansfield L, Park HS. Outcomes following Lower Extremity Amputation in Patients with Diabetes Mellitus and Peripheral Arterial Disease Annals Of Vascular Surgery 2019, 63: 259-268. PMID: 31626926, DOI: 10.1016/j.avsg.2019.08.084.
1149P Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatmentHusain Z, Lee N, Eskander A, Park H, mehra S, Burtness B. 1149P Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment Annals Of Oncology 2019, 30: v466. DOI: 10.1093/annonc/mdz252.041.
Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant TherapyLOGANADANE G, KANN BH, PARK HS, JOHNSON SB, MEHRA S, JUDSON BL, BHATIA A, BELKACEMI Y, YARBROUGH WG, BURTNESS B, HUSAIN ZA. Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy Anticancer Research 2019, 39: 4885-4890. PMID: 31519591, DOI: 10.21873/anticanres.13674.
Strengths and limitations of large databases in lung cancer radiation oncology researchJairam V, Park HS. Strengths and limitations of large databases in lung cancer radiation oncology research Translational Lung Cancer Research 2019, 0: s172-s183. PMID: 31673522, PMCID: PMC6795574, DOI: 10.21037/tlcr.2019.05.06.
Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant TherapyLoganadane G, Kann B, Park H, Johnson S, Mehra S, Judson B, Bhatia A, Belkacemi Y, Yarbrough W, Burtness B, Husain Z. Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant Therapy International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e375-e376. DOI: 10.1016/j.ijrobp.2019.06.1628.
Error Types and Associations of Clinically Significant Events Within Food and Drug Administration Recalls of Linear Accelerators and Related ProductsJairam V, Lincoln H, Brown D, Park HS, Evans SB. Error Types and Associations of Clinically Significant Events Within Food and Drug Administration Recalls of Linear Accelerators and Related Products Practical Radiation Oncology 2019, 10: e8-e15. PMID: 31408733, DOI: 10.1016/j.prro.2019.08.001.
Overall survival is improved when DCIS accompanies invasive breast cancerKole AJ, Park HS, Johnson SB, Kelly JR, Moran MS, Patel AA. Overall survival is improved when DCIS accompanies invasive breast cancer Scientific Reports 2019, 9: 9934. PMID: 31289308, PMCID: PMC6616329, DOI: 10.1038/s41598-019-46309-2.
Treatment-Related Complications of Systemic Therapy and RadiotherapyJairam V, Lee V, Park HS, Thomas CR, Melnick ER, Gross CP, Presley CJ, Adelson KB, Yu JB. Treatment-Related Complications of Systemic Therapy and Radiotherapy JAMA Oncology 2019, 5: 1028-1035. PMID: 30946433, PMCID: PMC6583836, DOI: 10.1001/jamaoncol.2019.0086.
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database AnalysisJAIRAM V, KANN BH, PARK HS, MICCIO JA, BECKTA JM, YU JB, PRABHU RS, GAO SJ, MEHTA MP, CURRAN WJ, BINDRA RS, CONTESSA JN, PATEL KR. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis Anticancer Research 2019, 39: 2911-2918. PMID: 31177129, DOI: 10.21873/anticanres.13420.
Emergency department visits for prescription and synthetic opioid overdoses among patients with cancer.Jairam V, Yang D, Yu J, Park H. Emergency department visits for prescription and synthetic opioid overdoses among patients with cancer. Journal Of Clinical Oncology 2019, 37: 6579-6579. DOI: 10.1200/jco.2019.37.15_suppl.6579.
Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatmentLee NCJ, Eskander A, Park HS, Mehra S, Burtness BA, Husain Z. Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment Cancer 2019, 125: 2975-2983. PMID: 31090934, DOI: 10.1002/cncr.32161.
Quality at the American Society for Radiation Oncology Annual Meeting: Gender Balance Among Invited Speakers and Associations with Panel SuccessRahimy E, Jagsi R, Park HS, Moran JM, Cervino L, Albert A, Lee A, Evans S. Quality at the American Society for Radiation Oncology Annual Meeting: Gender Balance Among Invited Speakers and Associations with Panel Success International Journal Of Radiation Oncology • Biology • Physics 2019, 104: 987-996. PMID: 31085284, DOI: 10.1016/j.ijrobp.2019.05.005.
P50 Nationwide Patterns in Hospital Admissions for Bone Metastases and Associated Pathologic FracturesLee V, Jairam V, Yu J, Park H. P50 Nationwide Patterns in Hospital Admissions for Bone Metastases and Associated Pathologic Fractures International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e39. DOI: 10.1016/s0360-3016(19)30500-0.
P78 Treatment-Related Complications of Chemotherapy and Radiotherapy: An Analysis of the Nationwide Emergency Department SampleJairam V, Lee V, Park H, Thomas C, Melnick E, Gross C, Presley C, Adelson K, Yu J. P78 Treatment-Related Complications of Chemotherapy and Radiotherapy: An Analysis of the Nationwide Emergency Department Sample International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e51-e52. DOI: 10.1016/s0360-3016(19)30528-0.
P28 Rectal Radiation Dose Comparison Between Definitive Radiotherapy with Hydrogel Spacer Injection versus Post-prostatectomy Radiotherapy for Prostate CancerYang D, Yu J, An Y, Sprenkle P, Leapman M, Park H. P28 Rectal Radiation Dose Comparison Between Definitive Radiotherapy with Hydrogel Spacer Injection versus Post-prostatectomy Radiotherapy for Prostate Cancer International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e33. DOI: 10.1016/s0360-3016(19)30478-x.
MP29-16 THE ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT, INSURANCE STATUS, AND TREATMENT AMONG PATIENTS WITH TESTICULAR CANCERHsiang W, Jemal A, Nguyen K, Shuch B, Park H, Yu J, Gross C, Davidoff A, Leapman* M. MP29-16 THE ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT, INSURANCE STATUS, AND TREATMENT AMONG PATIENTS WITH TESTICULAR CANCER Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000557551.36748.5c.
OA01 Impact of Contralateral Lymph Node Involvement on Survival of Surgically-Managed HPV-Positive Oropharyngeal Cancer Staged with the AJCC Eighth EditionMiccio J, Kelly J, Kann B, An Y, Park H, Verma V, Mehra S, Judson B, Burtness B, Husain Z. OA01 Impact of Contralateral Lymph Node Involvement on Survival of Surgically-Managed HPV-Positive Oropharyngeal Cancer Staged with the AJCC Eighth Edition International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e1. DOI: 10.1016/s0360-3016(19)30402-x.
PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDBChowdhary M, Lee A, Gao S, Barry P, Diaz R, Bagadiya N, Park H, Yu J, Wilson L, Moran M, Higgins S, Knowlton C, Patel K. PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDB Radiotherapy And Oncology 2019, 133: s15. DOI: 10.1016/s0167-8140(19)30465-7.
P09 Radiotherapy Timing Following Biopsy and Its Effect on Overall Survival in Unresected Glioblastoma MultiformeGao S, Corbin Z, Moliterno J, Bindra R, Yu J, Park H, Contessa J. P09 Radiotherapy Timing Following Biopsy and Its Effect on Overall Survival in Unresected Glioblastoma Multiforme International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e26. DOI: 10.1016/s0360-3016(19)30459-6.
Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinomaLee NCJ, Kelly JR, An Y, Park HS, Judson BL, Burtness BA, Husain ZA. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma Cancer 2019, 125: 2018-2026. PMID: 30748002, PMCID: PMC6541535, DOI: 10.1002/cncr.32001.
AUTHOR REPLYLeapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. AUTHOR REPLY Urology 2019, 124: 106. PMID: 30784707, DOI: 10.1016/j.urology.2018.07.043.
Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinomaKann BH, Verma V, Stahl JM, Ross R, Dosoretz AP, Shafman TD, Gross CP, Park HS, Yu JB, Decker RH. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma Radiotherapy And Oncology 2019, 134: 44-49. PMID: 31005223, DOI: 10.1016/j.radonc.2019.01.027.
Head and Neck CancersTrifiletti D, Zaorsky N, Park H. Head and Neck Cancers 2019, 133-196. DOI: 10.1007/978-3-319-96809-4_4.
Suicide among cancer patientsZaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM. Suicide among cancer patients Nature Communications 2019, 10: 207. PMID: 30643135, PMCID: PMC6331593, DOI: 10.1038/s41467-018-08170-1.
Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer DatabaseChowdhary M, Lee A, Gao S, Wang D, Barry PN, Diaz R, Bagadiya NR, Park HS, Yu JB, Wilson LD, Moran MS, Higgins SA, Knowlton CA, Patel KR. Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database Frontiers In Oncology 2019, 8: 678. PMID: 30693271, PMCID: PMC6339938, DOI: 10.3389/fonc.2018.00678.
Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trialsYu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Mahajan A, Omay S, Chiang V. Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trials Journal Of Radiation Oncology 2019, 8: 39-46. DOI: 10.1007/s13566-018-0370-7.
Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoptionLi H, Torabi SJ, Park HS, Yarbrough WG, Mehra S, Choi R, Judson BL. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption The Laryngoscope 2018, 129: 1844-1855. PMID: 30575965, DOI: 10.1002/lary.27740.
Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United StatesBledsoe T, Park H, Rutter C, Aneja S, Nguyen PL, Yu J. Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States American Journal Of Clinical Oncology 2018, 41: 1062-1068. PMID: 29521648, DOI: 10.1097/coc.0000000000000423.
Treatment-Related Complications of Chemotherapy and Radiation Therapy: An Analysis of the Nationwide Emergency Department SampleJairam V, Park H, Yu J. Treatment-Related Complications of Chemotherapy and Radiation Therapy: An Analysis of the Nationwide Emergency Department Sample International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e416-e417. DOI: 10.1016/j.ijrobp.2018.07.1221.
Systemic Therapy with Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non-Small Cell Lung Carcinoma (NSCLC): A Multi-institutional AnalysisKann B, Miccio J, Stahl J, Verma V, Dosoretz A, Park H, Shafman T, Gross C, Yu J, Decker R. Systemic Therapy with Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non-Small Cell Lung Carcinoma (NSCLC): A Multi-institutional Analysis International Journal Of Radiation Oncology • Biology • Physics 2018, 102: s10-s11. DOI: 10.1016/j.ijrobp.2018.06.119.
Evolving National Practice Patterns of Hypofractionated Stereotactic Radiation Therapy Versus Single-Fraction Radiosurgery for Brain MetastasesJairam V, Kann B, Patel K, Yu J, Hansen J, Husain Z, Bindra R, Contessa J, Omay S, Chiang V, Park H. Evolving National Practice Patterns of Hypofractionated Stereotactic Radiation Therapy Versus Single-Fraction Radiosurgery for Brain Metastases International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e227. DOI: 10.1016/j.ijrobp.2018.07.775.
Adjuvant External Beam Radiation Therapy for Surgically Resected, Non-Metastatic Anaplastic Thyroid CancerSaeed N, Kelly J, Deshpande H, Bhatia A, Burtness B, Judson B, Mehra S, Osborn H, Yarbrough W, Peter P, Holt E, Decker R, Husain Z, Park H. Adjuvant External Beam Radiation Therapy for Surgically Resected, Non-Metastatic Anaplastic Thyroid Cancer International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e290-e291. DOI: 10.1016/j.ijrobp.2018.07.923.
Defining an Intermediate Risk Group for Low Grade Glioma? An Analysis of the National Cancer DatabaseJairam V, Kann B, Park H, Miccio J, Beckta J, Yu J, Gao S, Prabhu R, Mehta M, Curran W, Bindra R, Contessa J, Patel K. Defining an Intermediate Risk Group for Low Grade Glioma? An Analysis of the National Cancer Database International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e249-e250. DOI: 10.1016/j.ijrobp.2018.07.827.
A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose SelectionYu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Omay B, Chiang V. A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose Selection International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e372-e373. DOI: 10.1016/j.ijrobp.2018.07.1113.
Differing Radiation Doses Associated with Improved Overall Survival in Trimodality versus Bimodality Treatment for Esophageal CancerAnker C, Johnson S, Barry M, Heimann R, Borrazzo E, Park H, Lin S, Lester-Coll N. Differing Radiation Doses Associated with Improved Overall Survival in Trimodality versus Bimodality Treatment for Esophageal Cancer International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e25-e26. DOI: 10.1016/j.ijrobp.2018.07.507.
Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable CancersJohnson S, Park H, Gross C, Yu J. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable Cancers International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e399-e400. DOI: 10.1016/j.ijrobp.2018.07.1180.
Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysisKann BH, Miccio JA, Stahl JM, Ross R, Verma V, Dosoretz AP, Park HS, Shafman TD, Gross CP, Yu JB, Decker RH. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis Radiotherapy And Oncology 2018, 132: 188-196. PMID: 30391106, DOI: 10.1016/j.radonc.2018.10.017.
Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable CancersJohnson SB, Park HS, Gross CP, Yu JB. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers JAMA Oncology 2018, 4: 1375-1381. PMID: 30027204, PMCID: PMC6233773, DOI: 10.1001/jamaoncol.2018.2487.
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural NetworksKann BH, Aneja S, Loganadane GV, Kelly JR, Smith SM, Decker RH, Yu JB, Park HS, Yarbrough WG, Malhotra A, Burtness BA, Husain ZA. Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks Scientific Reports 2018, 8: 14036. PMID: 30232350, PMCID: PMC6145900, DOI: 10.1038/s41598-018-32441-y.
Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapyStahl JM, Qian JM, Tien CJ, Carlson DJ, Chen Z, Ratner ES, Park HS, Damast S. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy Supportive Care In Cancer 2018, 27: 1425-1433. PMID: 30187220, DOI: 10.1007/s00520-018-4441-5.
Adjuvant Chemotherapy Is Associated With Improved Survival for Late‐Stage Salivary Squamous Cell CarcinomaCheraghlou S, Schettino A, Zogg CK, Otremba MD, Bhatia A, Park HS, Osborn HA, Mehra S, Yarbrough WG, Judson BL. Adjuvant Chemotherapy Is Associated With Improved Survival for Late‐Stage Salivary Squamous Cell Carcinoma The Laryngoscope 2018, 129: 883-889. PMID: 30151947, DOI: 10.1002/lary.27444.
Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinomaLee NCJ, Kelly JR, Park HS, An Y, Judson BL, Burtness BA, Husain ZA. Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma Oral Oncology 2018, 85: 35-39. PMID: 30220317, DOI: 10.1016/j.oraloncology.2018.08.001.
Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate CancerLeapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate Cancer Urology 2018, 124: 98-106. PMID: 30107188, DOI: 10.1016/j.urology.2018.07.041.
Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomasLi H, Park HS, Osborn HA, Judson BL. Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas Cancers Of The Head & Neck 2018, 3: 4. PMID: 31093357, PMCID: PMC6460664, DOI: 10.1186/s41199-018-0031-y.
(OA37) High Rate of Distant Metastasis in High-Metastatic Node Number Human Papillomavirus-Positive Oropharyngeal CarcinomaLee N, Kelly J, Park H, Author T, An Y, Husain Z. (OA37) High Rate of Distant Metastasis in High-Metastatic Node Number Human Papillomavirus-Positive Oropharyngeal Carcinoma International Journal Of Radiation Oncology • Biology • Physics 2018, 101: e16. DOI: 10.1016/j.ijrobp.2018.02.076.
Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck CancerBreen W, Kelly J, Park HS, Son Y, Sasaki C, Wilson L, Decker R, Husain ZA. Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer Cureus 2018, 10: e2517. PMID: 29942720, PMCID: PMC6015992, DOI: 10.7759/cureus.2517.
PD42-01 NATIONAL TRENDS IN THE MANAGEMENT OF PATIENTS WITH POSITIVE SURGICAL MARGINS AT THE TIME OF RADICAL PROSTATECTOMYAmirkhiz K, Nguyen K, Hsiang W, Syed J, Suarez-Sarmiento A, Shuch B, Park H, Yu J, Leapman M. PD42-01 NATIONAL TRENDS IN THE MANAGEMENT OF PATIENTS WITH POSITIVE SURGICAL MARGINS AT THE TIME OF RADICAL PROSTATECTOMY Investigative Urology 2018, 199: e814. DOI: 10.1016/j.juro.2018.02.1954.
MP53-08 USE OF PROSTATE MAGNETIC RESONANCE IMAGING AMONG MEDICARE BENEFICIARIES WITH LOW-RISK PROSTATE CANCER IS ASSOCIATED WITH A HIGHER LIKELIHOOD OF DEFINITIVE TREATMENTLeapman M, Wang R, Park H, Yu J, Gross C, Ma X. MP53-08 USE OF PROSTATE MAGNETIC RESONANCE IMAGING AMONG MEDICARE BENEFICIARIES WITH LOW-RISK PROSTATE CANCER IS ASSOCIATED WITH A HIGHER LIKELIHOOD OF DEFINITIVE TREATMENT Investigative Urology 2018, 199: e707. DOI: 10.1016/j.juro.2018.02.1679.
Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancerKelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer Oral Oncology 2018, 79: 64-70. PMID: 29598952, DOI: 10.1016/j.oraloncology.2018.02.017.
National trends in the management of patients with positive surgical margins at the time of radical prostatectomy.Ghabili K, Nguyen K, Hsiang W, Syed J, Suarez-Sarmiento A, Shuch B, Park H, Yu J, Leapman M. National trends in the management of patients with positive surgical margins at the time of radical prostatectomy. Journal Of Clinical Oncology 2018, 36: 111-111. DOI: 10.1200/jco.2018.36.6_suppl.111.
Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non–Small Cell Lung CancerWang EH, Corso CD, Park HS, Chen AB, Wilson LD, Kim AW, Decker RH, Yu JB. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non–Small Cell Lung Cancer American Journal Of Clinical Oncology 2018, 41: 152-158. PMID: 26523443, DOI: 10.1097/coc.0000000000000245.
Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data BaseCheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL. Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data Base Cancer 2017, 124: 717-726. PMID: 29243245, DOI: 10.1002/cncr.31104.
Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States.Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB. Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States. Journal Of The National Comprehensive Cancer Network 2017, 15: 1494-1502. PMID: 29223987, DOI: 10.6004/jnccn.2017.7003.
Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical marginsGao SJ, Park HS, Corso CD, Rutter CE, Khan SA, Johung KL. Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins Journal Of Gastrointestinal Oncology 2017, 8: 953-961. PMID: 29299354, PMCID: PMC5750177, DOI: 10.21037/jgo.2017.08.12.
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryChowdhary M, Okwan-Duodu D, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Zhong J, Chapman BV, Bindra RS, Contessa JN, Park HS, Yu JB, Decker RH, Olson JJ, Oyesiku NM, Abrams RA, Shu HG, Curran WJ, Crocker IR, Patel KR. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery Journal Of Neuro-Oncology 2017, 136: 289-298. PMID: 29124649, PMCID: PMC5784434, DOI: 10.1007/s11060-017-2652-0.
Response.Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. Response. Journal Of The National Cancer Institute 2017, 110: 433-434. PMID: 29121329, DOI: 10.1093/jnci/djx230.
Adjuvant Therapy Use and Survival in Stage II Endometrial CancerLester-Coll NH, Young MR, Park HS, Ratner ES, Litkouhi B, Damast S. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer International Journal Of Gynecological Cancer 2017, 27: 1904-1911. PMID: 28763364, DOI: 10.1097/igc.0000000000001095.
Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomasYeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas Radiotherapy And Oncology 2017, 125: 258-265. PMID: 29054377, DOI: 10.1016/j.radonc.2017.09.027.
Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation TherapyHarder EM, Chen Z, Park HS, Mancini BR, Decker RH. Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy American Journal Of Clinical Oncology 2017, 40: 477-482. PMID: 26017483, DOI: 10.1097/coc.0000000000000195.
Adjuvant Radiation Therapy Improves Overall Survival After Margin-Positive Resection of Thymic CarcinomaJohnson S, Kole A, Bledsoe T, Park H, Decker R. Adjuvant Radiation Therapy Improves Overall Survival After Margin-Positive Resection of Thymic Carcinoma International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s211-s212. DOI: 10.1016/j.ijrobp.2017.06.523.
Increasing Utilization of Stereotactic Radiation Therapy as a Component of Initial Therapy in Metastatic Non–small Cell Lung CancerHayman T, Bledsoe T, Corso C, Lester-Coll N, Park H, Decker R. Increasing Utilization of Stereotactic Radiation Therapy as a Component of Initial Therapy in Metastatic Non–small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e459. DOI: 10.1016/j.ijrobp.2017.06.1702.
Predictors of Wrong Dose, Volume, or Targeting Events Within FDA Recalls of Linear AcceleratorsJairam V, Lincoln H, Brown D, Park H, Evans S. Predictors of Wrong Dose, Volume, or Targeting Events Within FDA Recalls of Linear Accelerators International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s71-s72. DOI: 10.1016/j.ijrobp.2017.06.175.
Extended Duration of Dilator Use Beyond 1 Year May Reduce Vaginal Stenosis After Intravaginal High-Dose-Rate BrachytherapyStahl J, Qian J, Park H, Tien C, Young M, Ratner E, Carlson D, Chen Z, Damast S. Extended Duration of Dilator Use Beyond 1 Year May Reduce Vaginal Stenosis After Intravaginal High-Dose-Rate Brachytherapy International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s228. DOI: 10.1016/j.ijrobp.2017.06.561.
Evaluation of Pathology-Based Staging for HPV-Associated Squamous Cell Carcinoma of the Oropharynx in a Large National SampleKelly J, An Y, Park H, Yarbrough W, Burtness B, Husain Z. Evaluation of Pathology-Based Staging for HPV-Associated Squamous Cell Carcinoma of the Oropharynx in a Large National Sample International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e347. DOI: 10.1016/j.ijrobp.2017.06.1430.
Survival Outcomes Among Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Patients Treated with Upfront Surgery Versus Definitive Chemoradiation TherapyKelly J, An Y, Park H, Yarbrough W, Burtness B, Husain Z. Survival Outcomes Among Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Patients Treated with Upfront Surgery Versus Definitive Chemoradiation Therapy International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s43-s44. DOI: 10.1016/j.ijrobp.2017.06.114.
Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary SyndromeKann B, Park H, Yeboa D, Aneja S, Girardi M, Foss F, Roberts K, Wilson L. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e430. DOI: 10.1016/j.ijrobp.2017.06.1632.
The Impact of Standardized Treatment Planning Guidelines on Treatment Plan QualityKelly J, Park H, Carlson D, Moran M, Wilson L, Young M, Higgins S, Guay D, Arthur G, Simmons W, Winter S, Evans S. The Impact of Standardized Treatment Planning Guidelines on Treatment Plan Quality International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e556. DOI: 10.1016/j.ijrobp.2017.06.1936.
Use of Alternative Medicine for Cancer and Its Impact on SurvivalJohnson S, Park H, Gross C, Yu J. Use of Alternative Medicine for Cancer and Its Impact on Survival International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e401. DOI: 10.1016/j.ijrobp.2017.06.1562.
Breast Cancer Survival is Improved When DCIS Accompanies Invasive Ductal CarcinomaKole A, Park H, Johnson S, Kelly J, Patel A. Breast Cancer Survival is Improved When DCIS Accompanies Invasive Ductal Carcinoma International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e25. DOI: 10.1016/j.ijrobp.2017.06.651.
Impact of Pathologic Lymph Node Number and Extranodal Extension on Overall Survival in Human Papillomavirus–Associated Oropharyngeal CancerLee N, Park H, Kelly J, An Y, Husain Z. Impact of Pathologic Lymph Node Number and Extranodal Extension on Overall Survival in Human Papillomavirus–Associated Oropharyngeal Cancer International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e352. DOI: 10.1016/j.ijrobp.2017.06.1442.
Radiosurgery for Brain Metastases: Practice Patterns and Disparities in the United StatesKann B, Park H, Chiang V, Yu J. Radiosurgery for Brain Metastases: Practice Patterns and Disparities in the United States International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e83-e84. DOI: 10.1016/j.ijrobp.2017.06.790.
Use of Alternative Medicine for Cancer and Its Impact on Survival.Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. Journal Of The National Cancer Institute 2017, 110: 121-124. PMID: 28922780, DOI: 10.1093/jnci/djx145.
Stage I Lung SBRT Clinical Practice PatternsCorso CD, Park HS, Moreno AC, Kim AW, Yu JB, Husain ZA, Decker RH. Stage I Lung SBRT Clinical Practice Patterns American Journal Of Clinical Oncology 2017, 40: 358-361. PMID: 25503436, DOI: 10.1097/coc.0000000000000162.
Comparison of Survival Outcomes Among Human Papillomavirus–Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational StudyKelly JR, Park HS, An Y, Contessa JN, Yarbrough WG, Burtness BA, Decker R, Husain Z. Comparison of Survival Outcomes Among Human Papillomavirus–Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study JAMA Oncology 2017, 3: 1107-1111. PMID: 28056116, PMCID: PMC5824218, DOI: 10.1001/jamaoncol.2016.5769.
Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settingsHong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, Ross R, Finkelstein SE, Dosoretz A, Park HS, Soulos PR, Evans SB. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings Practical Radiation Oncology 2017, 8: e79-e86. PMID: 28888675, DOI: 10.1016/j.prro.2017.07.005.
Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary SyndromeKann BH, Park HS, Yeboa DN, Aneja S, Girardi M, Foss FM, Roberts KB, Wilson LD. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome Clinical Lymphoma Myeloma & Leukemia 2017, 17: 520-526.e2. PMID: 28655598, DOI: 10.1016/j.clml.2017.05.017.
(P085) Trends in Stereotactic Body Radiation Therapy for Stage I Small Cell Lung CancerStahl J, Corso C, Verma V, Park H, Nath S, Husain Z, Simone C, Kim A, Decker R. (P085) Trends in Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2017, 98: e38. DOI: 10.1016/j.ijrobp.2017.02.181.
(S027) Hypofractionated Radiotherapy Is associated With Improved Overall Survival Among Patients With Early-Stage Glottic CancerBledsoe T, Park H, Stahl J, Yarbrough W, Burtness B, Decker R, Husain Z. (S027) Hypofractionated Radiotherapy Is associated With Improved Overall Survival Among Patients With Early-Stage Glottic Cancer International Journal Of Radiation Oncology • Biology • Physics 2017, 98: e8-e9. DOI: 10.1016/j.ijrobp.2017.02.063.
(S040) The Risk of Level IB Nodal Involvement in Oropharynx Cancer: Guidance for Submandibular Gland Sparing IrradiationLee N, Kelly J, Park H, Yarbrough W, Burtness B, Husain Z. (S040) The Risk of Level IB Nodal Involvement in Oropharynx Cancer: Guidance for Submandibular Gland Sparing Irradiation International Journal Of Radiation Oncology • Biology • Physics 2017, 98: e12. DOI: 10.1016/j.ijrobp.2017.02.076.
Use of alternative medicine for cancer and its impact on survival.Johnson S, Gross C, Park H, Yu J. Use of alternative medicine for cancer and its impact on survival. Journal Of Clinical Oncology 2017, 35: e18175-e18175. DOI: 10.1200/jco.2017.35.15_suppl.e18175.
Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node PositivityGao SJ, Park HS, Corso CD, Rutter CE, Kim AW, Johung KL. Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity The Annals Of Thoracic Surgery 2017, 104: 267-274. PMID: 28456393, DOI: 10.1016/j.athoracsur.2017.01.092.
Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA. Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival. Journal Of The National Cancer Institute 2017, 109 PMID: 28521361, DOI: 10.1093/jnci/djx042.
ResponseTchouta LN, Park HS, Boffa DJ, Blasberg JD, Detterbeck FC, Kim AW. Response CHEST Journal 2017, 151: 942-943. PMID: 28390633, DOI: 10.1016/j.chest.2017.01.017.
The prognostic value of extranodal extension in human papillomavirus‐associated oropharyngeal squamous cell carcinomaAn Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. The prognostic value of extranodal extension in human papillomavirus‐associated oropharyngeal squamous cell carcinoma Cancer 2017, 123: 2762-2772. PMID: 28323338, DOI: 10.1002/cncr.30598.
Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.Kole AJ, Stahl JM, Park HS, Khan SA, Johung KL. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer. Journal Of The National Comprehensive Cancer Network 2017, 15: 355-362. PMID: 28275036, DOI: 10.6004/jnccn.2017.0035.
A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell CarcinomaHusain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma JAMA Oncology 2017, 3: 358-365. PMID: 27737449, DOI: 10.1001/jamaoncol.2016.4581.
The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiationLee NCJ, Kelly JR, Park HS, Yarbrough WG, Burtness BA, Husain ZA. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation Practical Radiation Oncology 2017, 7: e317-e321. PMID: 28356201, DOI: 10.1016/j.prro.2017.02.004.
A Novel Prognostic Index for Ocular Adnexal LymphomaMeeks M, Park H, Yu J, Roberts K, Foss F, Wilson L. A Novel Prognostic Index for Ocular Adnexal Lymphoma Blood 2016, 128: 3597-3597. DOI: 10.1182/blood.v128.22.3597.3597.
Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young ChildrenKann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children JAMA Oncology 2016, 2: 1574-1581. PMID: 27491009, DOI: 10.1001/jamaoncol.2016.2547.
Trends in stereotactic body radiation therapy for stage I small cell lung cancerStahl JM, Corso CD, Verma V, Park HS, Nath SK, Husain ZA, Simone CB, Kim AW, Decker RH. Trends in stereotactic body radiation therapy for stage I small cell lung cancer Lung Cancer 2016, 103: 11-16. PMID: 28024690, DOI: 10.1016/j.lungcan.2016.11.009.
In Regard to Vaidya et alPark HS, Ma S, Wilson LD, Moran MS. In Regard to Vaidya et al International Journal Of Radiation Oncology • Biology • Physics 2016, 96: 706-707. PMID: 27681768, DOI: 10.1016/j.ijrobp.2016.06.2460.
Addition of Chemotherapy to Adjuvant Radiation Therapy is Associated With Improved Overall Survival in Adult MedulloblastomaKann B, Lester-Coll N, Park H, Yeboa D, Bindra R, Becker K, Baehring J, Roberts K. Addition of Chemotherapy to Adjuvant Radiation Therapy is Associated With Improved Overall Survival in Adult Medulloblastoma International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s27-s28. DOI: 10.1016/j.ijrobp.2016.06.080.
Comparison of Upfront Surgery Versus Chemoradiation for cT1-2 N1-2b Oropharynx Squamous Cell Carcinoma Based on Human Papillomavirus StatusKelly J, Park H, An Y, Decker R, Contessa J, Yarbrough W, Burtness B, Judson B, Husain Z. Comparison of Upfront Surgery Versus Chemoradiation for cT1-2 N1-2b Oropharynx Squamous Cell Carcinoma Based on Human Papillomavirus Status International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e327. DOI: 10.1016/j.ijrobp.2016.06.1451.
Facility Case Volume and Outcomes for Intensity Modulated Radiation Therapy in Head and Neck CancerPark H, Rutter C, Lester-Coll N, Corso C, Wang E, Wilson L, Yu J, Decker R, Husain Z. Facility Case Volume and Outcomes for Intensity Modulated Radiation Therapy in Head and Neck Cancer International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e325. DOI: 10.1016/j.ijrobp.2016.06.1444.
Who Benefits From Chemoradiation in Locally Advanced Endometrial Cancer? An Analysis of the National Cancer Data BaseLester-Coll N, Park H, Rutter C, Corso C, Young M, Ratner E, Litkouhi B, Decker R, Yu J, Damast S. Who Benefits From Chemoradiation in Locally Advanced Endometrial Cancer? An Analysis of the National Cancer Data Base International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e295. DOI: 10.1016/j.ijrobp.2016.06.1366.
Impact of Radiation Therapy Facility Case Volume on Survival in Anal CancerPark H, Stahl J, Lester-Coll N, Rutter C, Corso C, Wang E, Husain Z, Decker R, Yu J, Wilson L, Johung K. Impact of Radiation Therapy Facility Case Volume on Survival in Anal Cancer International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s188. DOI: 10.1016/j.ijrobp.2016.06.469.
Predictors of Nonadherence to National Comprehensive Cancer Network Management Guidelines for T1N0 Anal CancerKole A, Stahl J, Park H, Johung K. Predictors of Nonadherence to National Comprehensive Cancer Network Management Guidelines for T1N0 Anal Cancer International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e211. DOI: 10.1016/j.ijrobp.2016.06.1121.
Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young ChildrenKann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s230-s231. DOI: 10.1016/j.ijrobp.2016.06.573.
Modern Radiation Therapy for Left-Sided Breast Cancer: An Analysis of Mean Heart Dose Within Diverse Practice SettingsHong J, Gross C, Shafman T, Hu X, Yu J, Ross R, Dosoretz A, Park H, Finkelstein S, Soulos P, Evans S. Modern Radiation Therapy for Left-Sided Breast Cancer: An Analysis of Mean Heart Dose Within Diverse Practice Settings International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s209. DOI: 10.1016/j.ijrobp.2016.06.520.
The Prognostic Importance of Pathologic Extracapsular Extension in Human Papillomavirus–Associated Oropharyngeal Squamous Cell CarcinomaAn Y, Park H, Kelly J, Stahl J, Contessa J, Husain Z. The Prognostic Importance of Pathologic Extracapsular Extension in Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e346. DOI: 10.1016/j.ijrobp.2016.06.1500.
Hospital Volume and Outcomes of Robot-Assisted LobectomiesTchouta LN, Park HS, Boffa DJ, Blasberg JD, Detterbeck FC, Kim AW. Hospital Volume and Outcomes of Robot-Assisted Lobectomies CHEST Journal 2016, 151: 329-339. PMID: 27687847, DOI: 10.1016/j.chest.2016.09.008.
Association between access to accelerated partial breast irradiation and use of adjuvant radiotherapyWang EH, Park HS, Rutter CE, Gross CP, Soulos PR, Yu JB, Evans SB. Association between access to accelerated partial breast irradiation and use of adjuvant radiotherapy Cancer 2016, 123: 502-511. PMID: 27657353, DOI: 10.1002/cncr.30356.
Adjuvant chemotherapy and overall survival in adult medulloblastoma.Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro-Oncology 2016, 19: 259-269. PMID: 27540083, PMCID: PMC5464064, DOI: 10.1093/neuonc/now150.
Author ReplyLester-Coll NH, Park HS, Gross CP, Yu JB. Author Reply Urology 2016, 96: 134-135. PMID: 27492667, DOI: 10.1016/j.urology.2016.06.044.
Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain MetastasesColaco RJ, Park HS, Laurans MS, Chiang VS, Yu JB, Husain ZA. Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases Cureus 2016, 8: e679. PMID: 27563505, PMCID: PMC4985044, DOI: 10.7759/cureus.679.
The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate CancerLester-Coll NH, Park HS, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim SP, Gross CP, Yu JB. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer Urology 2016, 96: 128-135. PMID: 27392652, DOI: 10.1016/j.urology.2016.06.042.
Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control studySubramanian HE, Park HS, Barbieri A, Mahajan A, Judson BL, Mehra S, Yarbrough WG, Burtness BA, Husain ZA. Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study Cancers Of The Head & Neck 2016, 1: 7. PMID: 31093337, PMCID: PMC6460847, DOI: 10.1186/s41199-016-0008-7.
Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patientsStahl JM, Park HS, Silasi DA, Azodi M, Damast S. Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients Practical Radiation Oncology 2016, 6: 226-232. PMID: 27364883, DOI: 10.1016/j.prro.2015.09.015.
Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancerPark HS, Decker RH. Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer Cancers Of The Head & Neck 2016, 1: 5. PMID: 31093335, PMCID: PMC6457146, DOI: 10.1186/s41199-016-0005-x.
MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDRENKann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDREN Neuro-Oncology 2016, 18: iii105.2-iii105. PMCID: PMC4903595, DOI: 10.1093/neuonc/now076.36.
The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomasStahl JM, Corso CD, Park HS, An Y, Rutter CE, Han D, Roberts KB. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas European Journal Of Surgical Oncology 2016, 43: 168-174. PMID: 27335080, DOI: 10.1016/j.ejso.2016.05.031.
Who benefits from chemoradiation in stage III–IVA endometrial cancer? An analysis of the National Cancer Data BaseLester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner ES, Litkouhi B, Decker RH, Yu JB, Damast S. Who benefits from chemoradiation in stage III–IVA endometrial cancer? An analysis of the National Cancer Data Base Gynecologic Oncology 2016, 142: 54-61. PMID: 27151429, DOI: 10.1016/j.ygyno.2016.04.544.
Concurrent chemoradiotherapy versus radiotherapy alone for “biopsy‐only” glioblastoma multiformeKole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB. Concurrent chemoradiotherapy versus radiotherapy alone for “biopsy‐only” glioblastoma multiforme Cancer 2016, 122: 2364-2370. PMID: 27172136, DOI: 10.1002/cncr.30063.
Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patientsMancini BR, Park HS, Harder EM, Rutter CE, Corso CD, Decker RH, Husain ZA. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients Lung Cancer 2016, 97: 22-27. PMID: 27237023, DOI: 10.1016/j.lungcan.2016.04.011.
Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapyHarder EM, Park HS, Chen Z, Decker RH. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy Practical Radiation Oncology 2016, 6: e353-e359. PMID: 27156424, DOI: 10.1016/j.prro.2016.01.015.
Adjuvant hypofractionated partial-brain radiation therapy for pediatric Ewing sarcoma brain metastases: case report.van Dams R, Park HS, Alomari AK, Ricciardi AS, Rao H, McNamara J, DiLuna ML, Bindra RS. Adjuvant hypofractionated partial-brain radiation therapy for pediatric Ewing sarcoma brain metastases: case report. Journal Of Neurosurgery Pediatrics 2015, 17: 434-8. PMID: 26636250, DOI: 10.3171/2015.8.peds15313.
EPID-30PROGNOSTIC VALUE OF MGMT AND EXTENT OF RESECTION FOR GLIOBLASTOMAvan Dams R, Park H, Corso C, Rutter C, Bindra R, Yu J, Contessa J. EPID-30PROGNOSTIC VALUE OF MGMT AND EXTENT OF RESECTION FOR GLIOBLASTOMA Neuro-Oncology 2015, 17: v84-v85. PMCID: PMC4638770, DOI: 10.1093/neuonc/nov213.30.
Factors Associated With High-Volume Providers of Stereotactic Radiation Therapy for Medicare Beneficiaries in 2012Maroongroge S, Park H, Rutter C, Decker R, Yu J. Factors Associated With High-Volume Providers of Stereotactic Radiation Therapy for Medicare Beneficiaries in 2012 International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e352. DOI: 10.1016/j.ijrobp.2015.07.1444.
The Role of Chemoradiation in Elderly Limited-Stage Small Cell Lung Cancer PatientsCorso C, Rutter C, Park H, Lester-Coll N, Husain Z, Decker R. The Role of Chemoradiation in Elderly Limited-Stage Small Cell Lung Cancer Patients International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s160-s161. DOI: 10.1016/j.ijrobp.2015.07.384.
Survival Comparison of 3 Versus 4-5 Fractions for Stereotactic Body Radiation Therapy in Stage I Non-Small Cell Lung CancerPark H, Corso C, Rutter C, Kim A, Yu J, Husain Z, Decker R. Survival Comparison of 3 Versus 4-5 Fractions for Stereotactic Body Radiation Therapy in Stage I Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s100. DOI: 10.1016/j.ijrobp.2015.07.240.
Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung CancerWang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e387-e388. DOI: 10.1016/j.ijrobp.2015.07.1536.
Spine Stereotactic Body Radiation Therapy Outcomes in Patients With Concurrent Brain MetastasesPark H, Colaco R, Laurans M, Chiang V, Yu J, Husain Z. Spine Stereotactic Body Radiation Therapy Outcomes in Patients With Concurrent Brain Metastases International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e62. DOI: 10.1016/j.ijrobp.2015.07.702.
Pulmonary Dose Volume Predictors of Radiation Pneumonitis After Stereotactic Body Radiation TherapyHarder E, Park H, Chen Z, Decker R. Pulmonary Dose Volume Predictors of Radiation Pneumonitis After Stereotactic Body Radiation Therapy International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e427. DOI: 10.1016/j.ijrobp.2015.07.1635.
Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung CancerPark H, Wang E, Corso C, Rutter C, Wilson L, Kim A, Gross C, Yu J, Decker R. Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s186-s187. DOI: 10.1016/j.ijrobp.2015.07.447.
Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small Cell Lung CancerWang E, Corso C, Rutter C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e388-e389. DOI: 10.1016/j.ijrobp.2015.07.1538.
Influence of Robotic Hysterectomy on Delayed Vaginal Cuff Healing and Brachytherapy Initiation in Endometrial Carcinoma PatientsStahl J, Park H, Damast S. Influence of Robotic Hysterectomy on Delayed Vaginal Cuff Healing and Brachytherapy Initiation in Endometrial Carcinoma Patients International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e256. DOI: 10.1016/j.ijrobp.2015.07.1192.
The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic AdenocarcinomaRutter C, Park H, Corso C, Lester-Coll N, Mancini B, Yeboa D, Johung K. The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic Adenocarcinoma International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s154-s155. DOI: 10.1016/j.ijrobp.2015.07.368.
Comparison of Perioperative Chemotherapy and Adjuvant Chemoradiation in Resected Gastric CancerCorso C, Wang E, Lester-Coll N, Rutter C, Yeboa D, Mancini B, Yu J, Johung K, Park H. Comparison of Perioperative Chemotherapy and Adjuvant Chemoradiation in Resected Gastric Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e121. DOI: 10.1016/j.ijrobp.2015.07.855.
Stereotactic Body Radiation Therapy Versus Conventionally Fractionated Radiation Therapy: A Propensity Score Matched Analysis of Survival in Unresected Pancreatic CancerCorso C, Park H, Rutter C, Lester-Coll N, Mancini B, Yeboa D, Johung K. Stereotactic Body Radiation Therapy Versus Conventionally Fractionated Radiation Therapy: A Propensity Score Matched Analysis of Survival in Unresected Pancreatic Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s155-s156. DOI: 10.1016/j.ijrobp.2015.07.370.
Concurrent Chemoradiation Therapy Is Associated With Improved Survival Compared to Radiation Therapy Alone for Anaplastic GliomasYeboa D, Rutter C, Park H, Lester-Coll N, Corso C, Mancini B, Bindra R, Yu J. Concurrent Chemoradiation Therapy Is Associated With Improved Survival Compared to Radiation Therapy Alone for Anaplastic Gliomas International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s168. DOI: 10.1016/j.ijrobp.2015.07.404.
Practice Patterns of Concurrent Chemoradiation Therapy Compared to Radiation Therapy Alone for Low Grade GliomasYeboa D, Park H, Rutter C, Mancini B, Corso C, Lester-Coll N, Bindra R, Yu J. Practice Patterns of Concurrent Chemoradiation Therapy Compared to Radiation Therapy Alone for Low Grade Gliomas International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e73. DOI: 10.1016/j.ijrobp.2015.07.730.
Pediatric Brainstem Glioma Survival After Definitive Radiation Therapy With or Without Concurrent Chemotherapy: A Nationwide ComparisonPark H, Yeboa D, Lester-Coll N, Corso C, Mancini B, Bindra R, Roberts K, Yu J, Rutter C. Pediatric Brainstem Glioma Survival After Definitive Radiation Therapy With or Without Concurrent Chemotherapy: A Nationwide Comparison International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e504-e505. DOI: 10.1016/j.ijrobp.2015.07.1836.
Survival Benefit of Concurrent Chemoradiation Therapy for Unresected Glioblastoma Multiforme in the Temozolomide EraKole A, Yeboa D, Rutter C, Lester-Coll N, Corso C, Mancini B, Bindra R, Yu J, Park H. Survival Benefit of Concurrent Chemoradiation Therapy for Unresected Glioblastoma Multiforme in the Temozolomide Era International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e64. DOI: 10.1016/j.ijrobp.2015.07.706.
Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation SurgeryAn Y, Rutter C, Park H, Corso C, Mancini B, Lester-Coll N, Yeboa D, Evans S. Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation Surgery International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e54-e55. DOI: 10.1016/j.ijrobp.2015.07.680.
Central Neurocytoma: Impact of Resection Extent, Adjuvant Radiation Therapy, and Tumor Location on Survival OutcomesAn Y, Yu J, Park H. Central Neurocytoma: Impact of Resection Extent, Adjuvant Radiation Therapy, and Tumor Location on Survival Outcomes International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e113. DOI: 10.1016/j.ijrobp.2015.07.836.
Increasing Use of Post Lumpectomy Radiation Therapy for Ductal Carcinoma In Situ of the Breast in the United StatesAn Y, Rutter C, Park H, Stahl J, Corso C, Mancini B, Lester-Coll N, Yeboa D, Evans S. Increasing Use of Post Lumpectomy Radiation Therapy for Ductal Carcinoma In Situ of the Breast in the United States International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e50. DOI: 10.1016/j.ijrobp.2015.07.669.
Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate CancerLester-Coll N, Park H, Rutter C, Corso C, Mancini B, Yeboa D, Kim S, Gross C, Yu J. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s118. DOI: 10.1016/j.ijrobp.2015.07.281.
Stereotactic Body Radiation Therapy for Prostate Cancer: Adoption in the United States From 2005 to 2012Bledsoe T, Rutter C, Corso C, Aneja S, Lester-Coll N, Wang E, Potosky A, Gross C, Yu J, Park H. Stereotactic Body Radiation Therapy for Prostate Cancer: Adoption in the United States From 2005 to 2012 International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e359. DOI: 10.1016/j.ijrobp.2015.07.1462.
Minimally Invasive Surgery and External Beam Radiation Therapy Selection for Prostate Cancer Varies Significantly by Health Insurance StatusBledsoe T, Park H, Rutter C, Aneja S, Yu J. Minimally Invasive Surgery and External Beam Radiation Therapy Selection for Prostate Cancer Varies Significantly by Health Insurance Status International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e358-e359. DOI: 10.1016/j.ijrobp.2015.07.1461.
The Effect of Margin Status and Radiation Therapy on Survival in Adult Retroperitoneal Soft Tissue SarcomasStahl J, Corso C, An Y, Aneja S, Rutter C, Park H, Mancini B, Yeboa D, Lester-Coll N, Han D, Roberts K. The Effect of Margin Status and Radiation Therapy on Survival in Adult Retroperitoneal Soft Tissue Sarcomas International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e638. DOI: 10.1016/j.ijrobp.2015.07.2175.
Shifts in Stereotactic Radiosurgery Platform Utilization for Brain Metastases in the United StatesPark H, Wang E, Rutter C, Corso C, Chiang V, Yu J. Shifts in Stereotactic Radiosurgery Platform Utilization for Brain Metastases in the United States International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e62. DOI: 10.1016/j.ijrobp.2015.07.701.
Postmastectomy Radiation Therapy for Women With 1-3 Positive Axillary Lymph Nodes: Patterns of Care AnalysisPark H, Rutter C, An Y, Killelea B, Evans S. Postmastectomy Radiation Therapy for Women With 1-3 Positive Axillary Lymph Nodes: Patterns of Care Analysis International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e5. DOI: 10.1016/j.ijrobp.2015.07.557.
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung CancerCorso CD, Rutter CE, Park HS, Lester-Coll NH, Kim AW, Wilson LD, Husain ZA, Lilenbaum RC, Yu JB, Decker RH. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer Journal Of Clinical Oncology 2015, 33: 4240-4246. PMID: 26481366, PMCID: PMC4678178, DOI: 10.1200/jco.2015.62.4270.
Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. Journal Of Neurosurgery 2015, 124: 1018-24. PMID: 26473783, DOI: 10.3171/2015.4.jns1573.
Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data BaseRutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base Cancer 2015, 121: 4141-4149. PMID: 26280559, DOI: 10.1002/cncr.29652.
Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiationRutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation Lung Cancer 2015, 90: 243-248. PMID: 26277031, DOI: 10.1016/j.lungcan.2015.08.002.
Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapyHarder EM, Park HS, Nath SK, Mancini BR, Decker RH. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy Practical Radiation Oncology 2015, 5: e643-e649. PMID: 26412341, DOI: 10.1016/j.prro.2015.07.003.
Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung CancerWang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung Cancer Journal Of Clinical Oncology 2015, 33: 2727-2734. PMID: 26101240, DOI: 10.1200/jco.2015.61.1517.
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non–Small-Cell Lung CancerWang EH, Rutter CE, Corso CD, Decker RH, Wilson LD, Kim AW, Yu JB, Park HS. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non–Small-Cell Lung Cancer Journal Of Thoracic Oncology 2015, 10: 937-943. PMID: 25738221, DOI: 10.1097/jto.0000000000000519.
Factors associated with high-volume providers of stereotactic radiation therapy for Medicare beneficiaries in 2012.Maroongroge S, Park H, Rutter C, Decker R, Yu J. Factors associated with high-volume providers of stereotactic radiation therapy for Medicare beneficiaries in 2012. Journal Of Clinical Oncology 2015, 33: e17578-e17578. DOI: 10.1200/jco.2015.33.15_suppl.e17578.
Association between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer.Wang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer. Journal Of Clinical Oncology 2015, 33: 7538-7538. DOI: 10.1200/jco.2015.33.15_suppl.7538.
Racial disparities in the use of SBRT for treating early-stage lung cancerCorso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH. Racial disparities in the use of SBRT for treating early-stage lung cancer Lung Cancer 2015, 89: 133-138. PMID: 26051446, DOI: 10.1016/j.lungcan.2015.05.002.
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell Lung CancerPark HS, Harder EM, Mancini BR, Decker RH. Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell Lung Cancer Journal Of Thoracic Oncology 2015, 10: 832-837. PMID: 25634007, DOI: 10.1097/jto.0000000000000484.
Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinomaPark HS, Ratner ES, Lucarelli L, Polizzi S, Higgins SA, Damast S. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma Brachytherapy 2015, 14: 464-470. PMID: 25887343, DOI: 10.1016/j.brachy.2015.03.001.
Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-AnalysisOgembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, Ogembo JG. Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis PLOS ONE 2015, 10: e0122488. PMID: 25875167, PMCID: PMC4396854, DOI: 10.1371/journal.pone.0122488.
The evolving role of adjuvant radiotherapy for elderly women with early‐stage breast cancerRutter CE, Lester-Coll NH, Mancini BR, Corso CD, Park HS, Yeboa DN, Gross CP, Evans SB. The evolving role of adjuvant radiotherapy for elderly women with early‐stage breast cancer Cancer 2015, 121: 2331-2340. PMID: 25810128, DOI: 10.1002/cncr.29377.
Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United StatesRutter CE, Park HS, Killelea BK, Evans SB. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States Annals Of Surgical Oncology 2015, 22: 2378-2386. PMID: 25564175, DOI: 10.1245/s10434-014-4334-x.
Assessment of National Practice for Palliative Radiation Therapy for Bone Metastases Suggests Marked Underutilization of Single-Fraction Regimens in the United StatesRutter CE, Yu JB, Wilson LD, Park HS. Assessment of National Practice for Palliative Radiation Therapy for Bone Metastases Suggests Marked Underutilization of Single-Fraction Regimens in the United States International Journal Of Radiation Oncology • Biology • Physics 2014, 91: 548-555. PMID: 25542310, DOI: 10.1016/j.ijrobp.2014.10.045.
Prophylactic Cranial Irradiation for Patients With Locally Advanced Non–Small-Cell Lung Cancer at High Risk for Brain MetastasesPark HS, Decker RH, Wilson LD, Yu JB. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non–Small-Cell Lung Cancer at High Risk for Brain Metastases Clinical Lung Cancer 2014, 16: 292-297. PMID: 25499149, DOI: 10.1016/j.cllc.2014.11.005.
ACE Inhibitors Decrease the Risk of Radiation Pneumonitis Following SBRT Early-Stage Non-Small Cell Lung CancerHarder E, Park H, Mancini B, Decker R. ACE Inhibitors Decrease the Risk of Radiation Pneumonitis Following SBRT Early-Stage Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s13. DOI: 10.1016/j.ijrobp.2014.08.154.
Elderly Patients Undergoing SBRT for Inoperable Early-Stage NSCLC Achieve Similar Outcomes to Younger Patients Early-Stage Non-Small Cell Lung CancerMancini B, Park H, Harder E, Rutter C, Corso C, Decker R, Husain Z. Elderly Patients Undergoing SBRT for Inoperable Early-Stage NSCLC Achieve Similar Outcomes to Younger Patients Early-Stage Non-Small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s11. DOI: 10.1016/j.ijrobp.2014.08.149.
Demographic Disparities in SBRT Utilization for Stage I NSCLCCorso C, Park H, Moreno A, Kim A, Yu J, Husain Z, Decker R. Demographic Disparities in SBRT Utilization for Stage I NSCLC International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s575. DOI: 10.1016/j.ijrobp.2014.05.1734.
Elderly Patients Undergoing SBRT for Inoperable Early-Stage NSCLC Achieve Similar Outcomes to Younger PatientsMancini B, Park H, Harder E, Rutter C, Corso C, Decker R, Husain Z. Elderly Patients Undergoing SBRT for Inoperable Early-Stage NSCLC Achieve Similar Outcomes to Younger Patients International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s162. DOI: 10.1016/j.ijrobp.2014.05.656.
Does Central vs. Peripheral Tumor Location Impact Outcomes Following Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer?Park H, Harder E, Mancini B, Decker R. Does Central vs. Peripheral Tumor Location Impact Outcomes Following Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer? International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s28-s29. DOI: 10.1016/j.ijrobp.2014.05.132.
Trends in Stage I Lung SBRT Clinical Practice PatternsCorso C, Park H, Moreno A, Kim A, Husain Z, Yu J, Decker R. Trends in Stage I Lung SBRT Clinical Practice Patterns International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s158-s159. DOI: 10.1016/j.ijrobp.2014.05.647.
The Effect of Diabetes and Antidiabetic Drugs on Outcomes After Pulmonary SBRTHarder E, Park H, Mancini B, Decker R. The Effect of Diabetes and Antidiabetic Drugs on Outcomes After Pulmonary SBRT International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s639. DOI: 10.1016/j.ijrobp.2014.05.1894.
ACE Inhibitors Decrease the Risk of Radiation Pneumonitis Following SBRTHarder E, Park H, Mancini B, Decker R. ACE Inhibitors Decrease the Risk of Radiation Pneumonitis Following SBRT International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s638. DOI: 10.1016/j.ijrobp.2014.05.1892.
Dose-Volume Parameters for the Esophagus in Pulmonary SBRTHarder E, Chen Z, Park H, Mancini B, Decker R. Dose-Volume Parameters for the Esophagus in Pulmonary SBRT International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s59-s60. DOI: 10.1016/j.ijrobp.2014.05.206.
Predictors of Vaginal Stenosis Following Intra-vaginal High-Dose-Rate Brachytherapy for Endometrial CarcinomaPark H, Ratner E, Lucarelli L, Polizzi S, Higgins S, Damast S. Predictors of Vaginal Stenosis Following Intra-vaginal High-Dose-Rate Brachytherapy for Endometrial Carcinoma International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s111. DOI: 10.1016/j.ijrobp.2014.05.532.
Effect of Primary Treatment Modality on the Association Between Statins and Prostate Cancer Recurrence: An Updated Meta-analysisPark H, Schoenfeld J, Vega R, Shive M, Hartman R, Ogembo R, Mucci L. Effect of Primary Treatment Modality on the Association Between Statins and Prostate Cancer Recurrence: An Updated Meta-analysis International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s408. DOI: 10.1016/j.ijrobp.2014.05.1297.
Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United StatesRutter CE, Corso CD, Park HS, Mancini BR, Yeboa DN, Lester-Coll NH, Kim AW, Decker RH. Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States Lung Cancer 2014, 85: 390-394. PMID: 25001510, DOI: 10.1016/j.lungcan.2014.06.013.
Reply to ‘Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer’ by T. KawadaPark H, Schoenfeld J, Mucci L. Reply to ‘Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer’ by T. Kawada Annals Of Oncology 2014, 25: 543-544. PMID: 24419238, DOI: 10.1093/annonc/mdt565.
Lethality of Cardiovascular Events Highlights the Variable Impact of Complication Type Between Thoracoscopic and Open Pulmonary LobectomiesLaw TD, Boffa DJ, Detterbeck FC, Wang Z, Park HS, Kim AW. Lethality of Cardiovascular Events Highlights the Variable Impact of Complication Type Between Thoracoscopic and Open Pulmonary Lobectomies The Annals Of Thoracic Surgery 2013, 97: 993-999. PMID: 24370204, DOI: 10.1016/j.athoracsur.2013.10.026.
Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysisPark HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA. Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis Annals Of Oncology 2013, 24: 1427-1434. PMID: 23508824, PMCID: PMC3660083, DOI: 10.1093/annonc/mdt077.
Skull Base Chordoma and Chondrosarcoma: An Update of National Radiation Therapy Patterns and Survival Outcomes in the Modern EraPark H, Roberts K, Yu J. Skull Base Chordoma and Chondrosarcoma: An Update of National Radiation Therapy Patterns and Survival Outcomes in the Modern Era International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s286-s287. DOI: 10.1016/j.ijrobp.2012.07.748.
Using the Surveillance, Epidemiology, and End Results Database to Investigate Rare Cancers, Second Malignancies, and Trends in Epidemiology, Treatment, and OutcomesLloyd S, Park HS, Decker RH, Wilson LD, Yu JB. Using the Surveillance, Epidemiology, and End Results Database to Investigate Rare Cancers, Second Malignancies, and Trends in Epidemiology, Treatment, and Outcomes Current Problems In Cancer 2012, 36: 191-199. PMID: 22495057, DOI: 10.1016/j.currproblcancer.2012.03.008.
Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results DatabaseYu JB, Lloyd S, Decker RH, Wilson LD, Park HS. Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results Database Current Problems In Cancer 2012, 36: 208-215. PMID: 22481005, DOI: 10.1016/j.currproblcancer.2012.03.010.
Overview of the Surveillance, Epidemiology, and End Results Database: Evolution, Data Variables, and Quality AssurancePark HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the Surveillance, Epidemiology, and End Results Database: Evolution, Data Variables, and Quality Assurance Current Problems In Cancer 2012, 36: 183-190. PMID: 22481006, DOI: 10.1016/j.currproblcancer.2012.03.007.
Prediction Models, Nomograms, and Staging Validation with the Surveillance, Epidemiology, and End Results DatabaseLloyd S, Park HS, Wilson LD, Decker RH, Yu JB. Prediction Models, Nomograms, and Staging Validation with the Surveillance, Epidemiology, and End Results Database Current Problems In Cancer 2012, 36: 200-207. PMID: 22481008, DOI: 10.1016/j.currproblcancer.2012.03.009.
Limitations and Biases of the Surveillance, Epidemiology, and End Results DatabasePark HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Limitations and Biases of the Surveillance, Epidemiology, and End Results Database Current Problems In Cancer 2012, 36: 216-224. PMID: 22481009, DOI: 10.1016/j.currproblcancer.2012.03.011.
Immortal Time Bias: A Frequently Unrecognized Threat to Validity in the Evaluation of Postoperative RadiotherapyPark HS, Gross CP, Makarov DV, Yu JB. Immortal Time Bias: A Frequently Unrecognized Threat to Validity in the Evaluation of Postoperative Radiotherapy International Journal Of Radiation Oncology • Biology • Physics 2012, 83: 1365-1373. PMID: 22342097, DOI: 10.1016/j.ijrobp.2011.10.025.
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysisBuscariollo DL, Park HS, Roberts KB, Yu JB. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis Cancer 2011, 118: 4212-4219. PMID: 22213196, DOI: 10.1002/cncr.27373.
Outcomes Following Gamma Knife for MetastasesPark H, Yu J, Knisely J, Chiang V. Outcomes Following Gamma Knife for Metastases 2011 DOI: 10.5772/29841.
Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an updatePark HS, Chiang VL, Knisely JP, Raldow AC, Yu JB. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update Expert Review Of Anticancer Therapy 2011, 11: 1731-1738. PMID: 22050022, DOI: 10.1586/era.11.165.
Delayed Radiation-Induced Vasculitic LeukoencephalopathyRauch PJ, Park HS, Knisely JP, Chiang VL, Vortmeyer AO. Delayed Radiation-Induced Vasculitic Leukoencephalopathy International Journal Of Radiation Oncology • Biology • Physics 2011, 83: 369-375. PMID: 22024206, DOI: 10.1016/j.ijrobp.2011.06.1982.
Prophylactic Cranial Irradiation for High-Risk Patients with Locally Advanced Non-small Cell Lung CancerPark H, Decker R, Wilson L, Yu J. Prophylactic Cranial Irradiation for High-Risk Patients with Locally Advanced Non-small Cell Lung Cancer International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s627. DOI: 10.1016/j.ijrobp.2011.06.1866.
Impact of Hospital Volume of Thoracoscopic Lobectomy on Primary Lung Cancer OutcomesPark HS, Detterbeck FC, Boffa DJ, Kim AW. Impact of Hospital Volume of Thoracoscopic Lobectomy on Primary Lung Cancer Outcomes The Annals Of Thoracic Surgery 2011, 93: 372-379. PMID: 21945225, DOI: 10.1016/j.athoracsur.2011.06.054.
593 PRIMARY URETHRAL CANCER: TREATMENT PATTERNS IN THE U.S.Park H, Taylor B, Yu J. 593 PRIMARY URETHRAL CANCER: TREATMENT PATTERNS IN THE U.S. Investigative Urology 2011, 185: e239. DOI: 10.1016/j.juro.2011.02.1425.
Outcomes From 3144 Adrenalectomies in the United States: Which Matters More, Surgeon Volume or Specialty?Park HS, Roman SA, Sosa JA. Outcomes From 3144 Adrenalectomies in the United States: Which Matters More, Surgeon Volume or Specialty? JAMA Surgery 2009, 144: 1060-1067. PMID: 19917944, DOI: 10.1001/archsurg.2009.191.
Treatment patterns of aging Americans with differentiated thyroid cancerPark HS, Roman SA, Sosa JA. Treatment patterns of aging Americans with differentiated thyroid cancer Cancer 2009, 116: 20-30. PMID: 19908255, DOI: 10.1002/cncr.24717.

Clinical Trials

Conditions	Study Title
Lung	A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Larynx; Lip, Oral Cavity and Pharynx	A Randomized, Double-Blind Placebo-Controlled, Phase 3 Study of Debio 1143 in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
Lung	Phase 2 Trial of Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous Non-Small Cell Lung Cancer
Lung	MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Lung	Phase IB/II Trial Of Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
Urinary Bladder	Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer (Study SWOG/NRG 1806)
Prostate	Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Pancreas	Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma
Esophagus; Larynx; Lip, Oral Cavity and Pharynx	A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPCA
Lung	A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Participants With Medically Inoperable Stages I or IIA Non Small Cell Lung Cancer (NSCLC) (KEYNOTE-867)
Other Skin	A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630)
Breast - Female; Breast	TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Larynx; Lip, Oral Cavity and Pharynx	Phase II Randomized Trial of Adjuvant Radiotherapy With or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Larynx; Lip, Oral Cavity and Pharynx	Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer
Lip, Oral Cavity and Pharynx	Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Edit Profile

Henry S. Park, MD, MPH

Contact Information

Office Location

Related Links

Patient Care

Research & Publications

Biography

News